Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM

K-Number: K081165 · 2008-12-17

ApplicantSpineart
Decision Date2008-12-17
Product CodeMNH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Spineart. It received FDA 510(k) clearance on 2008-12-17 under 510(k) number K081165. The device is classified under product code MNH. It was reviewed by the OR advisory panel. Product code MNH falls under the category of ENT, which includes ear, nose, and throat diagnostic and surgical devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM?

ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM is a medical device that received FDA 510(k) clearance on 2008-12-17. The listed applicant is Spineart. The 510(k) number is K081165.

When did ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM receive FDA 510(k) clearance?

ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM received FDA 510(k) clearance on 2008-12-17, under 510(k) number K081165.

Who is the listed applicant for ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM?

The FDA 510(k) record lists Spineart as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM?

The FDA product code for ELLIPSE LUMBAR POSTERIOR OSTEOSYNTHESIS SYSTEM is MNH. This falls under the ENT category.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Spineart as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K230774PERLA® TL System; TEKTONA® HV US Bone CementK213470PERLA® TL Posterior Osteosynthesis SystemK210472SPINEART Navigation Instrument SystemK203506PERLA® TL posterior osteosynthesis systemK203222PERLA TL Posterior Osteosynthesis SystemK200571PERLA® Posterior Occipito-Cervico-Thoracic Fixation System

View all 34 devices →

Related Devices (Code: MNH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K162066Reliance Spinal Screw SystemReliance Medical Systems, LLCK162801CastleLoc Spinal Fixation SystemL&K BIOMED Co., Ltd.K162143FixxSure® X-LinkInnovasis, Inc.K161151Spinal fixation systemCanwell Medical Co., Ltd.K162189ANAX™ 5.5 Spinal SystemU&I CorporationK151362HC Spinal SystemHung Chun Bio-S Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑